期刊文献+

RNAi沉默WT1基因对人肝癌细胞HepG2的影响 被引量:2

Effect of RNAi silencing of theWT1 gene on the apoptosis of human hepatocellular carcinoma cell hepG2
下载PDF
导出
摘要 目的:探讨利用RNA干扰沉默WT1基因对人肝癌细胞HepG2细胞生长,凋亡的影响,为肝癌的基因治疗提供理论依据。方法:利用脂质体将siRNA真核表达载体转入HepG2细胞中,并检测转染效率;利用免疫细胞化学染色方法检测HepG2细胞中WT1蛋白水平的表达,测定基因沉默效果;用MTT法测定HepG2细胞生长曲线;电镜下观察细胞凋亡形态,流式细胞仪检测凋亡率。结果:利用脂质体为载体将siRNA真核表达载体转染HepG2细胞,转染率达70%以上,转染后细胞中WT1蛋白表达水平下降;RNA干扰沉默WT1基因可抑制细胞增殖,促进细胞凋亡。结论:靶向WT1的序列特异性siRNA可显著抑制WT1基因的表达;下调HepG2细胞WT1基因表达可抑制细胞增殖,促进细胞凋亡。 AIM: To inhibit the expression of WT1 gene in HepG2 cells by siRNA, to study the effect of WT1 on the proliferation and apoptosis. METHODS: HepG2 cells was transfected with WT1-siRNA by liposomes. The protein expression of WT1 in HepG2 cells was detected by immunocytochemistry to detect the effect of WT1 gene silencing. Tumor cells growth was detected by MTT assay. Morphology of apoptotic cells was observed by electron microscope and fluorescence. RESULTS: HepG2 cells was transfected with WT1-siRNA by liposomes, and the expression of WT1 were inhibited signifycantly. The transfection rate was over 70%. Silencing of WT1 by siRNA can inhibit cell proliferation and promote apoptosis. CONCLUSION: Sequence-specific siRNA targeting to WT1 can inhibit WT1 gene expression significantly. The decreesed expression of WT1 gene inhibits cell proliferation and promotes apoptosis of hepG2 cells.
作者 黄小琪
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2010年第8期771-773,共3页 Chinese Journal of Cellular and Molecular Immunology
关键词 WT1基因 RNAI 人肝癌细胞HEPG2 凋亡 WT1 RNAi human hepatocellular carcinoma cell hepG2 apoptosis
  • 相关文献

参考文献7

  • 1Qin Y, Zhu H, Jiang B, et al. Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease [ J ]. Leuk Res, 2009, 33 ( 3 ) : 384 - 390.
  • 2Oji Y, Ogawa H, Tamaki H, et al. Expression of the Wilms'tumor gene WT 1 in solid tumors and its involvement in tumor cell growth [J]. Jpn J Cancer Res, 1999, 90(2) : 194 -204.
  • 3Keilholz U, Letseh A, Busse A, et al. A clinical and immunological phase II trial of Wilms tumor gene product 1 ( WT1 ) peptide vaccination in patients with AML and MDS[J]. Blood, 2009, 113(26): 6541 - 6548.
  • 4Oka Y, Tsuboi A, Elisseeva OA, et al. WTI peptide cancer vaccine for patients with hematopoietic malignancies and solid cancers[ J]. Sci Worl J, 2007, 29 (7) : 649 - 665.
  • 5Clark AJ, Ware JL, Chen MY, et al. Effect ofWT1 gene silencing on the tumori-genicity of human glioblastoma multiforme cells[ J]. J Neurosurg, 2009, 112(1): 18-25.
  • 6Tatsumi N, Oji Y, Tsuji N, et al. Wilmstumor gene WTl-shRNA as a potent apoptosis-inducing agent for solid tumors [ J ]. Int J Oncol, 2008, 32(3): 701 -711.
  • 7Barbolina MV, Adley BP, Shea LD, et al. Wilms tumor gene protein 1 is asso-ciated with ovarian cancer metastasis and modulates cell invasion[J]. Cancer, 2008, 112(7) : 1632 - 1641.

同被引文献8

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部